Table 2. Detailed characteristics of acute upper gastrointestinal bleeding in patients with gastric malignancy.

No.	Age, y	Sex	ASA grade	Initial Hb, g/dL	Shock 1	Transfused pRBCs, unit	Forrest classification	Tumor type	Location	Size, mm	Comorbidity	Antiplatelet agent use	GBS	AIMS65 score	Rockall score
1	65	M	II	8.9	No	0	Ib	AGC	Lower	30	None	No	7	1	8
2	64	M	III	6.5	No	6	Ib	AGC	Lower	50	DM	No	7	1	8
3	89	F	IV	6.9	No	2	Ib	AGC	Diffuse	35	AF, old TB	No	13	1	8
4	57	F	III	5.4	No	6	Ib	AGC	Lower	30	None	No	12	1	8
5	85	F	III	6.0	No	5	Ib	AGC	Lower	50	HTN, DM	Aspirin	10	2	8
6	74	M	III	7.6	No	3	Ib	AGC	Lower	40	COPD, old TB	No	8	2	8
7	64	M	IV	7.0	No	4	Ib	AGC	Diffuse	15	Pneumonia	No	12	2	7
8	77	M	III	6.3	No	2	Ib	AGC	Diffuse	40	HTN, DM, CAD, old CVA, COPD	Aspirin Clopidogrel	12	2	8
9	68	M	II	7.2	No	2	Ib	AGC	Upper	50	None	No	8	2	8
10	74	F	II	6.2	Yes	2	Ib	AGC	Lower	100	None	No	15	3	10
11	73	M	III	6.7	No	4	Ib	AGC	Lower	40	CAD, HTN	Aspirin Clopidogrel	12	2	7
12	72	M	II	6.8	No	4	Ib	GIST	Upper	25	None	No	7	2	5

ASA, American Society of Anesthesiologists; Hb, hemoglobin; pRBCs, packed red blood cells; GBS, Glasgow-Blatchford score; AGC, advanced gastric cancer; GIST, gastrointestinal stromal tumor; DM, diabetes mellitus; AF, atrial fibrillation; TB, tuberculosis; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CVA, cerebrovascular accident

¹Shock means systolic blood pressure < 90 mmHg